Evidence map›Paper›PMID 40718777›Full record

ArticlePeerJ2025

Curcumin inhibits type III secretion of

Miguel Diaz-Guerrero, Luis Esaú López-Jácome, Rafael Franco-Cendejas, Rafael Coria-Jiménez, María Guadalupe Martínez-Zavaleta, Bertha González-Pedrajo, Daniel Huelgas-Méndez, Rodolfo García-Contreras

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miguel Diaz-GuerreroFaculty of Medicine, Department of Microbiology and Parasitology, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Luis Esaú López-JácomeLaboratorio de Microbiología Clínica, División de Infectología, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.
Rafael Franco-CendejasSubdirección de Investigación Biomédica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.
Rafael Coria-JiménezLaboratory of Experimental Bacteriology, Instituto Nacional de Pediatria, Mexico City, Mexico.
María Guadalupe Martínez-ZavaletaLaboratorio de Microbiología Clínica, División de Infectología, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.
Bertha González-PedrajoDepartamento de Genética Molecular, Instituto de Fisiología Celular, UNAM, Mexico City, Mexico.
Daniel Huelgas-MéndezFaculty of Medicine, Department of Microbiology and Parasitology, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Rodolfo García-ContrerasFaculty of Medicine, Department of Microbiology and Parasitology, Universidad Nacional Autónoma de México, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCurcuminPseudomonas aeruginosaType III Secretion SystemsBacterial ProteinsBurnsHumansPseudomonas InfectionsQuorum SensingVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsCurcuminType III Secretion SystemsVirulence FactorsClinical isolatesInjectisomeMultidrug resistanceNatural productsVirulence

Identifiers

PMID40718777
PMCPMC12296563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.